Skip to main content
. 2023 Jul 3;78(8):2019–2027. doi: 10.1093/jac/dkad200

Figure 3.

Figure 3.

Cumulative percentage MIC distributions of cefiderocol and comparator agents against MBL-producing P. aeruginosa strains. (a) IMP-producing P. aeruginosa (n = 25). Data for strains above the upper end of the MIC measurement range are not plotted. Cefepime MIC values were >16 mg/L against all strains, so not plotted on graph. Ceftazidime/avibactam MIC values were >16 mg/L against all strains, so not plotted on graph. Ceftolozane/tazobactam MIC values were >16 mg/L against all strains, so not plotted on graph. Ciprofloxacin MIC values were >8 mg/L against all strains, so not plotted on graph. In the colistin plot, the MIC value of 0.25 mg/L means ≤0.25 mg/L. IMP-producing P. aeruginosa were screened among P. aeruginosa with meropenem MICs  ≥ 4 mg/L, so meropenem MICs are not plotted below 4 mg/L. (b) VIM-producing P. aeruginosa (n = 200). Data for strains above the upper end of the MIC measurement range are not plotted. In the ciprofloxacin plot, the MIC value of 0.12 mg/L means ≤0.12 mg/L. In the colistin plot, the MIC value of 0.25 mg/L means ≤0.25 mg/L. VIM-producing P. aeruginosa were screened among P. aeruginosa with meropenem MICs  ≥ 4 mg/L, so meropenem MICs are not plotted below 4 mg/L.